Sofinnova Venture Partners VIII, L.P.
Insider CIK 1524064 · ALIM 10% owner · HSGX 10% owner · PRNB 10% owner · VSAR 10% owner · MIRN 10% owner · ACRS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 453,954 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 625,482 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 521,235 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 625,482 | — | $0 | 625,482 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2018-09-18 | 2018-09-20 | 270,000 | $17.00 | $4.59M | 2,038,208 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 1,768,208 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 453,954 | — | $0 | 1,600,671 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 521,235 | — | $0 | 1,146,717 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,424,242 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,063,107 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,000,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-13 | 2015-10-13 | 409,090 | $11.00 | $4.50M | 2,289,480 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion | 2015-10-13 | 2015-10-13 | 1,880,390 | — | $0 | 1,880,390 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-06 | 857,142 | $7.00 | $6.00M | 2,974,811 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-06 | 289,841 | — | $0 | 2,117,669 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 1,244,269 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 1,244,269 | — | $0 | 1,244,269 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 1,827,828 | SEC↗ |
| HSGX HISTOGENICS CORP | X Exercise deriv | 2014-12-08 | 2014-12-10 | 14,569 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion deriv | 2014-12-08 | 2014-12-10 | 960,345 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion deriv | 2014-12-08 | 2014-12-10 | 611,738 | — | $0 | 0 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion | 2014-12-08 | 2014-12-10 | 960,345 | — | $0 | 960,345 | SEC↗ |
| HSGX HISTOGENICS CORP | X Exercise | 2014-12-08 | 2014-12-10 | 14,569 | $0.76 | $11.1K | 1,586,652 | SEC↗ |
| HSGX HISTOGENICS CORP | S Sale | 2014-12-08 | 2014-12-10 | 1,002 | $11.00 | $11.0K | 1,585,650 | SEC↗ |
| HSGX HISTOGENICS CORP | P Buy | 2014-12-08 | 2014-12-10 | 500,198 | $11.00 | $5.50M | 2,085,848 | SEC↗ |
| HSGX HISTOGENICS CORP | J Other | 2014-12-08 | 2014-12-10 | 8,808 | — | $0 | 2,077,040 | SEC↗ |
| HSGX HISTOGENICS CORP | C Conversion | 2014-12-08 | 2014-12-10 | 611,738 | — | $0 | 1,572,083 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other | 2014-09-12 | 2014-09-15 | 2,000,000 | — | $0 | 506,270 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | J Other | 2014-09-12 | 2014-09-15 | 40,020 | — | $0 | 40,020 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2014-09-11 | 2014-09-15 | 166,667 | — | $0 | 83,333 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2014-09-11 | 2014-09-15 | 2,506,270 | $2.66 | $6.67M | 2,506,270 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 775,315 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 802,596 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 485,664 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion deriv | 2014-03-26 | 2014-03-28 | 23,403 | — | $0 | 0 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 485,664 | — | $0 | 2,086,978 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2014-03-26 | 2014-03-28 | 60,000 | $21.00 | $1.26M | 2,146,978 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 23,403 | — | $0 | 23,403 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 775,315 | — | $0 | 798,718 | SEC↗ |
| VSAR Versartis, Inc. | C Conversion | 2014-03-26 | 2014-03-28 | 802,596 | — | $0 | 1,601,314 | SEC↗ |